Cargando…

The choroid plexus: a door between the blood and the brain for tissue-type plasminogen activator

BACKGROUND: In the vascular compartment, the serine protease tissue-type plasminogen activator (tPA) promotes fibrinolysis, justifying its clinical use against vasculo-occlusive diseases. Accumulating evidence shows that circulating tPA (endogenous or exogenous) also controls brain physiopathologica...

Descripción completa

Detalles Bibliográficos
Autores principales: Zuba, Vincent, Furon, Jonathane, Bellemain-Sagnard, Mathys, Martinez de Lazarrondo, Sara, Lebouvier, Laurent, Rubio, Marina, Hommet, Yannick, Gauberti, Maxime, Vivien, Denis, Ali, Carine
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9569045/
https://www.ncbi.nlm.nih.gov/pubmed/36243724
http://dx.doi.org/10.1186/s12987-022-00378-0
_version_ 1784809778644516864
author Zuba, Vincent
Furon, Jonathane
Bellemain-Sagnard, Mathys
Martinez de Lazarrondo, Sara
Lebouvier, Laurent
Rubio, Marina
Hommet, Yannick
Gauberti, Maxime
Vivien, Denis
Ali, Carine
author_facet Zuba, Vincent
Furon, Jonathane
Bellemain-Sagnard, Mathys
Martinez de Lazarrondo, Sara
Lebouvier, Laurent
Rubio, Marina
Hommet, Yannick
Gauberti, Maxime
Vivien, Denis
Ali, Carine
author_sort Zuba, Vincent
collection PubMed
description BACKGROUND: In the vascular compartment, the serine protease tissue-type plasminogen activator (tPA) promotes fibrinolysis, justifying its clinical use against vasculo-occlusive diseases. Accumulating evidence shows that circulating tPA (endogenous or exogenous) also controls brain physiopathological processes, like cerebrovascular reactivity, blood–brain barrier (BBB) homeostasis, inflammation and neuronal fate. Whether this occurs by direct actions on parenchymal cells and/or indirectly via barriers between the blood and the central nervous system (CNS) remains unclear. Here, we postulated that vascular tPA can reach the brain parenchyma via the blood-cerebrospinal fluid barrier (BCSFB), that relies on choroid plexus (CP) epithelial cells (CPECs). METHODS: We produced various reporter fusion proteins to track tPA in primary cultures of CPECs, in CP explants and in vivo in mice. We also investigated the mechanisms underlying tPA transport across the BCSFB, with pharmacological and molecular approaches. RESULTS: We first demonstrated that tPA can be internalized by CPECs in primary cultures and in ex vivo CPs explants. In vivo, tPA can also be internalized by CPECs both at their basal and apical sides. After intra-vascular administration, tPA can reach the cerebral spinal fluid (CSF) and the brain parenchyma. Further investigation allowed discovering that the transcytosis of tPA is mediated by Low-density-Lipoprotein Related Protein-1 (LRP1) expressed at the surface of CPECs and depends on the finger domain of tPA. Interestingly, albumin, which has a size comparable to that of tPA, does not normally cross the CPs, but switches to a transportable form when grafted to the finger domain of tPA. CONCLUSIONS: These findings provide new insights on how vascular tPA can reach the brain parenchyma, and open therapeutic avenues for CNS disorders. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12987-022-00378-0.
format Online
Article
Text
id pubmed-9569045
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-95690452022-10-16 The choroid plexus: a door between the blood and the brain for tissue-type plasminogen activator Zuba, Vincent Furon, Jonathane Bellemain-Sagnard, Mathys Martinez de Lazarrondo, Sara Lebouvier, Laurent Rubio, Marina Hommet, Yannick Gauberti, Maxime Vivien, Denis Ali, Carine Fluids Barriers CNS Research BACKGROUND: In the vascular compartment, the serine protease tissue-type plasminogen activator (tPA) promotes fibrinolysis, justifying its clinical use against vasculo-occlusive diseases. Accumulating evidence shows that circulating tPA (endogenous or exogenous) also controls brain physiopathological processes, like cerebrovascular reactivity, blood–brain barrier (BBB) homeostasis, inflammation and neuronal fate. Whether this occurs by direct actions on parenchymal cells and/or indirectly via barriers between the blood and the central nervous system (CNS) remains unclear. Here, we postulated that vascular tPA can reach the brain parenchyma via the blood-cerebrospinal fluid barrier (BCSFB), that relies on choroid plexus (CP) epithelial cells (CPECs). METHODS: We produced various reporter fusion proteins to track tPA in primary cultures of CPECs, in CP explants and in vivo in mice. We also investigated the mechanisms underlying tPA transport across the BCSFB, with pharmacological and molecular approaches. RESULTS: We first demonstrated that tPA can be internalized by CPECs in primary cultures and in ex vivo CPs explants. In vivo, tPA can also be internalized by CPECs both at their basal and apical sides. After intra-vascular administration, tPA can reach the cerebral spinal fluid (CSF) and the brain parenchyma. Further investigation allowed discovering that the transcytosis of tPA is mediated by Low-density-Lipoprotein Related Protein-1 (LRP1) expressed at the surface of CPECs and depends on the finger domain of tPA. Interestingly, albumin, which has a size comparable to that of tPA, does not normally cross the CPs, but switches to a transportable form when grafted to the finger domain of tPA. CONCLUSIONS: These findings provide new insights on how vascular tPA can reach the brain parenchyma, and open therapeutic avenues for CNS disorders. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12987-022-00378-0. BioMed Central 2022-10-15 /pmc/articles/PMC9569045/ /pubmed/36243724 http://dx.doi.org/10.1186/s12987-022-00378-0 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Zuba, Vincent
Furon, Jonathane
Bellemain-Sagnard, Mathys
Martinez de Lazarrondo, Sara
Lebouvier, Laurent
Rubio, Marina
Hommet, Yannick
Gauberti, Maxime
Vivien, Denis
Ali, Carine
The choroid plexus: a door between the blood and the brain for tissue-type plasminogen activator
title The choroid plexus: a door between the blood and the brain for tissue-type plasminogen activator
title_full The choroid plexus: a door between the blood and the brain for tissue-type plasminogen activator
title_fullStr The choroid plexus: a door between the blood and the brain for tissue-type plasminogen activator
title_full_unstemmed The choroid plexus: a door between the blood and the brain for tissue-type plasminogen activator
title_short The choroid plexus: a door between the blood and the brain for tissue-type plasminogen activator
title_sort choroid plexus: a door between the blood and the brain for tissue-type plasminogen activator
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9569045/
https://www.ncbi.nlm.nih.gov/pubmed/36243724
http://dx.doi.org/10.1186/s12987-022-00378-0
work_keys_str_mv AT zubavincent thechoroidplexusadoorbetweenthebloodandthebrainfortissuetypeplasminogenactivator
AT furonjonathane thechoroidplexusadoorbetweenthebloodandthebrainfortissuetypeplasminogenactivator
AT bellemainsagnardmathys thechoroidplexusadoorbetweenthebloodandthebrainfortissuetypeplasminogenactivator
AT martinezdelazarrondosara thechoroidplexusadoorbetweenthebloodandthebrainfortissuetypeplasminogenactivator
AT lebouvierlaurent thechoroidplexusadoorbetweenthebloodandthebrainfortissuetypeplasminogenactivator
AT rubiomarina thechoroidplexusadoorbetweenthebloodandthebrainfortissuetypeplasminogenactivator
AT hommetyannick thechoroidplexusadoorbetweenthebloodandthebrainfortissuetypeplasminogenactivator
AT gaubertimaxime thechoroidplexusadoorbetweenthebloodandthebrainfortissuetypeplasminogenactivator
AT viviendenis thechoroidplexusadoorbetweenthebloodandthebrainfortissuetypeplasminogenactivator
AT alicarine thechoroidplexusadoorbetweenthebloodandthebrainfortissuetypeplasminogenactivator
AT zubavincent choroidplexusadoorbetweenthebloodandthebrainfortissuetypeplasminogenactivator
AT furonjonathane choroidplexusadoorbetweenthebloodandthebrainfortissuetypeplasminogenactivator
AT bellemainsagnardmathys choroidplexusadoorbetweenthebloodandthebrainfortissuetypeplasminogenactivator
AT martinezdelazarrondosara choroidplexusadoorbetweenthebloodandthebrainfortissuetypeplasminogenactivator
AT lebouvierlaurent choroidplexusadoorbetweenthebloodandthebrainfortissuetypeplasminogenactivator
AT rubiomarina choroidplexusadoorbetweenthebloodandthebrainfortissuetypeplasminogenactivator
AT hommetyannick choroidplexusadoorbetweenthebloodandthebrainfortissuetypeplasminogenactivator
AT gaubertimaxime choroidplexusadoorbetweenthebloodandthebrainfortissuetypeplasminogenactivator
AT viviendenis choroidplexusadoorbetweenthebloodandthebrainfortissuetypeplasminogenactivator
AT alicarine choroidplexusadoorbetweenthebloodandthebrainfortissuetypeplasminogenactivator